Plain-English answer
Diabetes in China is a large chronic-care challenge. It requires prevention, early diagnosis, affordable medication, glucose monitoring, blood pressure and lipid control, kidney and eye screening, foot care, and long-term primary-care follow-up.
Recent national survey
A JAMA study found estimated adult diabetes prevalence rose from 10.9 percent in 2013 to 12.4 percent in 2018, while prediabetes was 38.1 percent in 2018.
What diabetes changes
Diabetes becomes expensive when it is not controlled. The burden appears as heart attack, stroke, kidney disease, retinopathy, neuropathy, foot ulcers, amputations, infections, and pregnancy complications. That makes diabetes a system issue rather than a single disease label. It requires a reliable care loop: screening, diagnosis, medication, monitoring, complication checks, lifestyle support, and escalation when needed.
The JAMA national survey used data from more than 170,000 adults in each survey period. It estimated that diabetes prevalence increased from 10.9 percent in 2013 to 12.4 percent in 2018. In 2018, only 36.7 percent of adults with diabetes reported awareness of their condition, 32.9 percent reported treatment, and 50.1 percent of treated patients had adequate glycemic control. Those figures point to a care cascade problem. The disease exists before the system has identified or controlled it.
Why it matters
Diabetes connects directly to China's aging, obesity, and cardiovascular burdens. The same survey found increases in low physical activity, high red-meat intake, overweight, and obesity from 2013 to 2018. Diabetes care therefore cannot be separated from nutrition, urban lifestyles, primary care, pharmacies, employer health programs, and patient education.
Specialist hospitals are important for complications and complex cases, but routine diabetes management has to happen closer to daily life. Community health centers and family doctor teams can track glucose, blood pressure, medication adherence, eye and kidney screening, and foot checks. If those functions are weak, tertiary hospitals receive preventable complications that should have been avoided years earlier.
Care-cascade caution
Diabetes prevalence alone is not enough. The key questions are awareness, treatment, control, complication screening, affordability, and follow-up.
How to read the pathway
Find the undiagnosed
Screening and routine checkups matter because many patients do not know they have diabetes.
Keep treatment affordable
Medication, insulin, testing supplies, and visits must be financially sustainable.
Prevent complications
Kidney, eye, cardiovascular, nerve, and foot complications define much of the long-term cost.
Strategic meaning
For strategy, diabetes is a primary-care and data-continuity test. Glucose meters, CGM, digital coaching, SGLT2 and GLP-1 drugs, insulin delivery, retinal screening, kidney tests, and remote monitoring all need a pathway that someone owns. The strongest opportunities will connect clinical evidence with reimbursement, community workflow, patient adherence, and complication prevention.
Research anchors
| Source | What it adds | How to use it |
|---|---|---|
| JAMA diabetes prevalence and treatment study | Provides 2013-2018 prevalence, prediabetes, awareness, treatment, and control data. | Use it for care-cascade analysis. |
| Frontiers obesity projection study | Links rising obesity to diabetes and other NCD risks. | Use it for upstream risk context. |
| CDC NCDs in China | Places diabetes within China's larger NCD burden. | Use it for population-health framing. |